Fighting Against Cancer with Non-Hodgkin Lymphoma Therapeutics
The rising number of cancer cases is a major concern in the healthcare sector, with stomach cancer cases on the rise. To address this challenging lymphatic system cancer, Non-Hodgkin Lymphoma Therapeutics emerges as a pivotal approach. These groundbreaking treatment options are revolutionizing cancer management, transforming the way we tackle the disease, and striving for complete eradication.
So, let’s explore the types, benefits, and advanced treatment options to alleviate cancer.
What are Non-Hodgkin Lymphoma Therapeutics?
Non-Hodgkin Lymphoma Therapeutics is an innovative treatment approach for non-Hodgkin lymphoma cancer. This cancer typically develops in the lymphatic system, which is part of the body’s immune system. The treatment of this cancer depends on several factors, including the type and stage of the disease, the patient’s overall health condition, and their preferences. These therapeutics have shown promising results in recent years while improving outcomes for many patients.
5 Common Types of Non-Hodgkin Lymphoma Therapeutics
NHL therapeutics are categorized into various types. Some of the therapeutic types include:
1. Chemotherapy
Chemotherapy is a common treatment for NHL. It involves the various types of medications to kill or stop the growth of cancer cells. It can be given orally or intravenously, and it can be used in combination with other treatments.
2. Radiation Therapy
This therapy uses high-energy X-rays or other types of radiation to prevent the growth and kill the cancerous cells. It is often used in combination with chemotherapy or as a standalone treatment for localized NHL.
3. Immunotherapy
This type of treatment helps the immune system fight with cancerous cells. It uses substances made by the body or in laboratory settings to direct, boost, or restore the body’s natural defenses against cancer.
4. Targeted Therapy
Targeted therapy uses drugs that only target cancer cells or the processes that support their growth. These drugs can interfere with specific molecules involved in cancer cell growth and their survival.
5. Stem Cell Transplantation
Stem cell transplantation, or bone marrow transplant, is an innovative procedure that replaces damaged bone marrow with healthy stem cells. It is used in cases of aggressive or relapsed disease.
7 Potential Benefits of Non-Hodgkin Lymphoma Therapeutics
Below are the seven major benefits that NHL Therapeutics offers:
- Certain therapeutics, such as targeted therapies for NHL, can effectively target and kill cancer cells.
- They offer improved survival rates for patients with non-Hodgkin lymphoma.
- They can help control the progression of the disease and prevent its further spread.
- They can alleviate symptoms associated with the NHL, such as fatigue and pain.
- They can help preserve the function of affected organs such as the lymph nodes or bone marrow.
- NHL treatment plans can be tailored to their specific subtype of NHL to optimize outcomes.
- The combination of different types of therapeutics enhances effectiveness and targets cancer cells from multiple angles.
Latest Advances in Non-Hodgkin Lymphoma Therapeutics
Below are the three latest technological advancements in NHL treatment that are simplifying cancer therapy with enhanced precision.
● Proton therapy
Proton therapy is an advanced radiation therapy technique that delivers precise radiation doses to tumors. It helps minimize the damage to surrounding healthy tissues. It is being used in the treatment of NHL and can be available at specialized centers. One such example is the Texas Center for Proton Therapy, which offers advanced proton therapy technology, including pencil-beam scanning and image-guided therapy. Its roton therapy, known as precision tumor treatment, targets the cancer cells while minimizing damage to surrounding healthy tissues.
● CAR T-cell Therapy
CAR T-cell therapy is a groundbreaking treatment that involves modifying a patient’s immune cells to recognize and attack cancer cells. It has shown promising results in early clinical trials against some hard-to-treat lymphomas.
In this field, Kite Pharma offers a CAR T-cell therapy product called axicabtagene ciloleucel, also known by the trade name Yescarta. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of aggressive diffuse large B-cell lymphoma (DLBCL).
● Monoclonal Antibodies
Monoclonal antibodies have been developed for the treatment of lymphoma. These antibodies can precisely target cancer cells and help the immune system destroy them.
One of the best examples of this is rituximab, developed by Genentech and used in the treatment of B-cell non-Hodgkin lymphomas. Rituximab particularly targets the CD20 antigen found on the surface of B lymphocytes, helping to destroy cancer cells and slow down the progression of the disease.
Bottom Line
The non-Hodgkin lymphoma therapeutics market has made tremendous strides in recent years, offering a range of treatment options. From chemotherapy to targeted therapies and immunotherapies, these treatment options improve patient outcomes and quality of life. The advancements in NHL therapeutics, such as proton therapy, CAR T-cell therapy, and monoclonal antibodies, are paving the way for efficient cancer management and patient experiences. With continuous advancements, in the future, NHL therapeutics may enhance therapies and improve survival rates for individuals battling the disease.